All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
October 2023: Update to sildenafil
News
October 2023: Update to sildenafil
Secondary Raynauld's phenomenon / digital ulceration in systemic sclerosis in adults (off-label) has been reclassified from a red (hospital only) option to an amber (specialist input) option. The formulary entry includes supporting information.
Tablets 20mg and oral suspension sugar-free 10mg/1ml have been added to the formulary as red (hospital only) options for the treatment of pulmonary hypertension.
Click here for the formulary entry.
